NCT05764720View on ClinicalTrials.gov

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

NARecruitingINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

May 14, 2023

Primary Completion Date

February 15, 2026

Study Completion Date

February 15, 2028

Conditions

Pancreatic Cancer

Interventions

RADIATION

Daily Adaptive External Beam Radiation Therapy

Daily adaptive external beam radiation therapy delivered on Varian Ethos treatment system.

Trial Locations (2)

44106

RECRUITING

UH Cleveland Medical Center, Cleveland

63130

RECRUITING

Washington University, St. Louis, St Louis

All Listed Sponsors

collaborator

Washington University School of Medicine

OTHER

lead

Varian, a Siemens Healthineers Company

INDUSTRY

NCT05764720 - Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach | Biotech Hunter | Biotech Hunter